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Background: Understanding young women and men’s perceived barriers and
facilitators to participation in biomedical HIV prevention research is important for
designing youth friendly services (YFS) and acceptable technologies, which are
necessary for preventing high sustained HIV incidence in South Africa. This study
explores the multileveled barriers and facilitators to young men and women’s willingness
to participate in hypothetical biomedical HIV prevention research.
Methods: Eight age- (16–18 and 19–24 years) and gender-stratified focus group
discussions (FGDs) were conducted using semi-structured interview guides to explore
young South African women and men’s willingness, perceived barriers, and facilitators
to participating in biomedical HIV prevention research. FGD transcripts were uploaded
to NVivo and coded collaboratively with youth study team members. Thematic analysis
using Bronfenbrenner’s ecological model (individual, inter-personal, community, and
societal) was used to guide a deductive coding procedure, which was documented and
compared by gender.
Results: Thirty-one participants from Durban and 34 from Soweto participated in
FGDs. Individual facilitators for participation were discussed more by young men and
included financial incentives and altruism. Concerns about side-effects of biomedical
products were a common barrier. Interpersonal relationships with peers, intimate partners
and caregivers influenced young people’s willingness to participate in HIV prevention
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research, more so among young women. For young women, gendered power dynamics
and distrust of intimate partners and parents influenced both communication regarding
participation and willingness to participate in research that is often stigmatized, due to
societal norms around women’s sexuality. On a societal level, participants expressed
distrust in medical and research institutions, however a sense of community that
was developed with the study staff of this project, was a motivator to participate in
future studies.
Discussion: At each level of the ecological model, we found participants expressed
gendered barriers and facilitators for participation. Gender norms as well as distrust
of partners, parents, and health care professionals were key barriers that cut across
all levels. At each level participants discussed facilitators that were youth-engaged,
underscoring the need to implement YFS, establish trust and address gender inequities
within future biomedical HIV prevention studies wishing to engage and retain South
African youth.
Keywords: sexual and reproductive health, young people, South Africa, youth-friendly services, gender, biomedical
HIV prevention, socioecological model
INTRODUCTION
In South Africa, the nation with the highest number of people
living with HIV (∼7 million) worldwide, young women aged 15–
24 face the highest HIV incidence, accounting for ∼2,000 new
infections every week (1). Numerous bio-behavioral strategies
exist to effectively prevent HIV transmission including, HIV
testing and counseling (2), use of antiretroviral therapy (ART)
to achieve viral suppression among people living with HIV
(UequalsU), consistent condom use, male medical circumcision
(MMC) (3), and pre- and post- exposure prophylaxis (PrEP, PEP)
among others (4–6).
Advances in biomedical HIV prevention technologies such
as oral daily PrEP have shown efficacy, with protection
variation largely explained by differences in PrEP adherence
and trial retention (7). Across several implementation trials and
demonstration projects, adolescent girls and young women in
sub-Saharan Africa, have experienced particular challenges to
PrEP uptake, adherence, and retention (7). Thus, while PrEP
is highly effective when taken as directed (8), due to many
intersecting barriers, young people who have the greatest unmet
need for HIV prevention modalities, are not fully benefiting
from PrEP programming (7). Similar challenges have been noted
for youth participation in HIV vaccine research highlighting
that women may feel ambivalent toward participating in HIV
prevention research, because of a general mistrust toward clinical
trials (9), and that adolescents and young adults in South Africa
who are at greater risk of acquiring HIV, may be less willing to
participate in HIV vaccine trails (10). While some research has
quantitatively examined differences in youth whomay bemore or
less likely to participate in biomedical HIV research, with much
of the focus being on HIV vaccine trials (10), there is less of
an understanding as to why some young men and women may
be more or less willing to participate. As researchers continue
to discover, develop, and implement HIV prevention strategies
including new PrEP formulations and dosage (e.g., long-acting
injectable PrEP (11, 12), vaginal microbicides, vaginal rings)
and preventative HIV vaccines, it is paramount that studies are
inclusive to the needs of adolescents and young adults (13).
Decision-making about participating in biomedical HIV
prevention research is complex (14). Most research on
willingness to participate in HIV vaccine studies and other
biomedical trials has focused on individual-level barriers and
facilitators including personal concerns about PrEP safety and
potential side-effects, the personal value of participating in
research (e.g., benefits of care received and compensation),
and valuing being able to contribute to the enhancement
of knowledge (15). Few studies, however, have considered
the broader multi-leveled determinants that shape decisions
to participate. One Tanzanian-based study highlighted that
beyond individual-level determinants, community attitudes
toward research and structural impediments including stigma,
unemployment and poverty play an important role in research
participation willingness (16). Results from qualitative research
examining views of HPV vaccination among South African
youth and their caregivers found that the decision to vaccinate
was youth-led, highlighting high levels of youth autonomy
in health-related decision-making (17). Further research is
needed to explore how gender intersects with the multi-leveled
determinants and factors that influence young men and women’s
decision to participate in biomedical HIV prevention trials.
The dynamic inter-relations between individual and broader
social and environmental factors that shape decision-making are
conceptualized in Bronfenbrenner’s ecological framework (18).
This framework and model acknowledges that any outcome
cannot be explained by one factor, but instead is the result
of a number of interacting factors at different relational and
structural levels; individual, interpersonal, community, and
societal/institutional or structural. This framework has been used
in adolescent and youth research in numerous global contexts
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(19), including research on understanding young women’s risk
of HIV in South Africa (6).
Young people living in today’s South Africa are the first
generation of youth growing up post-apartheid (1994–current).
Despite living their whole lives in the new democratic republic,
historical legacies of colonialism and apartheid persist to
influence the ways in which young people form identities and
relationships (20). For example, in the face of adversity, low
employment opportunities, and high levels of poverty, young
men who are unable to achieve hegemonic forms of masculinity,
may form masculine identities that are more controlling, violent,
and in turn increase the risk of HIV among young women
(21, 22). Further, the formation of differing forms of femininity,
which either are acquiescent to persistent gender inequities or
seek to resist current gender norms impact the ways in which
young women form relationships (23). This body of literature
is situated within Connell’s theory of gender and power, which
mainly focuses on power dynamics between men and women
within intimate relationships and how these dynamics influence
decision-making processes that effect the health andwell-being of
women (24). We seek to extend the theory of gender and power
beyond power interactions within male and female intimate
relationships. In doing so, we wish to explore the ways in which
power and gender intersect at each level of the ecological model
to influence young men and women’s ability and willingness to
participate in biomedical HIV research.
The aim of this qualitative study was to explore the perceived
barriers and facilitators to participating in hypothetical HIV
biomedical prevention research for young women andmen living
in Durban and Soweto, South Africa. Using the ecological model,
we sought to explore the influence of gender and power dynamics
at individual, interpersonal, community, and societal levels on
willingness to participate. Results from this study can provide
researchers, policy makers, and program developers with the
knowledge required to better tailor HIV prevention research
programming, to improve youth engagement.
METHODS
Study Setting and Design
The AYAZAZI Study
This was a qualitative sub-study of the AYAZAZI study,
a multi-site, interdisciplinary, prospective cohort focused
on understanding linked patterns of socio-behavioral and
biomedical HIV risk among youth aged 16–24 years in Durban
and Soweto, South Africa (25). The Durban cohort was based
at the Commercial City site of the MatCH Research Unit
(MRU) while the Soweto cohort was based at the Perinatal HIV
Research Unit (PHRU) at Chris Hani Baragwanath Hospital.
Acknowledging the historical and social-political landscapes of
HIV research among youth, the AYAZAZI study was grounded
in a youth-engagement approach (26, 27).
Between November 2015 and April 2016, 425 youth (aged 16–
24 years; HIV negative or unknown HIV status) were enrolled
in AYAZAZI and completed baseline procedures, including a
quantitative bio-behavioral questionnaire, and were followed
every 6 months until 12 months (Durban) or 18 months
(Soweto). Additional details of the AYAZAZI study methodology
have been previously reported (25, 28, 29).
Qualitative Component
Participant Recruitment for FGDs
Within 6 months of enrollment, a purposive sample of AYAZAZI
participants were invited to participate in this qualitative sub-
study. We examined baseline questionnaire responses to “how
willing are you to participate biomedical HIV prevention
and/or vaccine research studies research” and randomly sampled
participants who reported being “willing,” “neutral,” or “not
willing” to participate in biomedical HIV prevention research,
stratifying by gender and age category (16–18 and 19–24 years).
Sampled participants were invited to participate in one of eight
age- and gender-stratified FGDs, four in Durban and four in
Soweto. Those who were interested and willing to participate
in FGDs were invited to the respective study sites to receive
additional information about the qualitative sub-study. FGDs
occurred in April and May 2015 at the PHRU and in July 2016
at the MRU. Participants were included if they had responded
to baseline questions regarding willingness to participate in HIV
prevention and/or vaccine research, were residing in Soweto or
Durban, and were able to provide written informed consent or
parental consent and participant written assent if under the age
of 18. Participants were excluded from recruitment if they were
currently participating in another clinical or observational HIV
prevention study.
Data Collection for FGDs
Prior to each FGD, trained youth research assistants led
an information session with experienced multi-lingual co-
facilitators trained in qualitative research methods on what
is involved in participating in HIV prevention research such
as HIV vaccine trials, MMC studies, PrEP studies, and other
studies requesting collection of blood, urine, vaginal swabs (for
female participants), seminal fluids (for male participants), and
rectal (males and females) samples. The information sessions
were delivered in English and used PowerPoint slides and
handouts for the participants. However, the facilitators were
able to explain concepts and answer participants’ questions
in IsiZulu or Sesotho, as preferred by participants. Female
facilitators led information sessions for female FGDs, and male
facilitators led sessions formale FGDs. Following the information
session, the facilitator began the FGD. The FGD guide asked
participants about their willingness to participate in different
types of biomedical HIV research and the reasons that informed
their willingness. FGDs were conducted in English although
participants were invited to respond in their preferred language
and clarifications were made by facilitators in other languages
as needed. FGDs including the information session, lasted from
60 to 90min. All FGDs were audio-recorded, translated (as
necessary), and transcribed. In order to maintain confidentiality,
participants chose pseudonyms that were used within the
transcripts. De-identified transcripts were uploaded to NVivo 12
for analysis (30).
Socio-demographic characteristics reported during the
AYAZAZI baseline survey were linked using participant study
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TABLE 1 | Ensuring trustworthiness through a collaborative, youth-engaged thematic analysis process.
Phase of Thematic Analysis Steps to ensure trustworthiness
1. Familiarization with the data • The analysis plan was collaboratively developed by team members in Canada and South Africa
• Each team member read through all transcripts
• A summary was developed for each transcript and reviewed by all team members
• Initial reflections about potential codes and themes were recorded
2. Generating initial codes • A codebook was developed collaboratively by the team, including two youth research assistants
• Each code was defined, ensuring input from members from each research site
• Regular team meetings were held to discuss the analysis process and encourage reflexivity
3. Searching for themes • Each transcript was double-coded
• Emerging themes were discussed, and interconnected concepts explored
• Each transcript was printed out and co-coded line for line by team members and youth research assistants and
emerging themes and sub-themes were discussed
4. Reviewing themes • Transcripts were re-read to verify themes
• In weekly team meetings with the global team, the codebook was revised as codes were grouped under one or
more themes
5. Defining and naming themes • Meetings were held with the global team to refine the codebook and to discuss the interpretation and definition
of concepts related to themes and sub-themes
• The codebook was finalized with codes categorized under themes and sub-themes
6. Producing the report • The team ensured that the analysis process was described in detail, including reasons for methodological and
analytical choices, and that descriptions of context was included in all reports
Adapted from Nowell et al. (32), p. 4.
IDs to identify and highlight the diversity of the sample of
youth who participated in the FGDs. Socio-demographic
characteristics included site (Durban, Soweto), age (continuous),
sexual orientation (lesbian, gay, or bisexual vs. heterosexual),
ever had children (yes vs. no), and formal vs. informal housing
(e.g., shack, hostel, reconstruction development program
[RDP] housing). Participants responses to the whether they
would be willing to participate in a HIV vaccine trial (willing,
neutral, unwilling) were also recorded at baseline, and linked to
participants in the FGDs.
Data Analysis
To analyze the qualitative data from the FGDs, a team of
researchers from Canada and South Africa carried out a
collaborative thematic analysis process that prioritized youth
engagement. The six Thematic Analysis phases defined by Braun
and Clark (31) and Nowell et al. (32) were followed and steps
were taken during each phase to ensure trustworthiness (See
Table 1). With the goal of gaining a deep understanding of young
women and men’s views and perspectives on participating in
different types of biomedical HIV research, inductive coding
was primarily done, as the data was drawn on to determine
themes. Some deductive coding was applied later based on the
socioecological framework (See Figure 1). Analysis was guided
by a latent approach, as the research team read into the
subtext in the data and the relational dimensions that were
explored by participants. As codes, sub-themes and themes
developed, these were verified collaboratively, including with two
young researchers who participated in each step of the process.
We used participant pseudonyms, chosen by the participants,
to share direct quotes from the FGDs that exemplified the
sub-themes.
Ethical Considerations
All participants aged 18–24 years provided voluntary informed
consent at enrollment. For participants aged 16–17 years,
parents/legal guardians provided voluntary written informed
consent and the participant provided voluntary written informed
assent. Ethical approval for these procedures was provided
by the Office of Research Ethics (ORE) of Simon Fraser
University (Canada) and the Human Research Ethics Committee
(HREC) of the University of the Witwatersrand (South Africa),




In total 65 youth aged 16–24 years (48% young women)
participated in the FGDs. Table 2 presents baseline socio-
demographic characteristics of the sample overall and stratified
by gender. Just over half of participants were from Soweto and
9.2% identified as lesbian, gay or bisexual. At baseline 23% had
ever had a child, 75% lived in formal housing, and 71% reported
being a student/learner. During the baseline questionnaire when
asked if participants of the FGDs would be willing to participate
in an HIV vaccine trial 28% indicated they were unwilling, 29%
indicated they were neutral, and 43% indicated they were willing.
More young women than young men reported being neutral
about HIV vaccine participation (39% vs. 21%) and more young
men than young women were willing to participate in HIV
vaccine trials (50% vs. 36%).
Findings
Throughout the FGDs, youth spoke of barriers and facilitators
to participating in biomedical HIV prevention research. Given
that young men and women participated in separate FGDs,
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FIGURE 1 | Young women and men’s social relationships at various levels of
their social environment (18).
they were enabled to explore gendered experiences and
perspectives, and the barriers and facilitators spoken about were
multileveled, occurring on individual, interpersonal, community,
and structural lines. Below we present common barriers and
facilitators to participation at each level of the ecological
model. We highlight and note gender differences at each
level and summarize cross-cutting barriers and facilitators that
shaped young women and men’s willingness to participate in
hypothetical biomedical HIV prevention research.
Individual
Common individual-level factors that served as facilitators to
participation in HIV prevention biomedical studies included
opportunities to access food, financial incentives, sexual health
information, and other forms of sexual and reproductive health
care that are commonly included as part of study visits. Perceived
barriers centered around a lack of information about the HIV
preventionmodality and the fear of side-effects, particularly from
PrEP and HIV vaccine candidates.
In the younger-aged female FGDs, participants discussed
enjoying being provided reimbursement and something to eat,
which they experienced as part of participating in AYAZAZI1.
Phumla2: “I like the fact that you always give us money when we
come here”.
Lena: “I like that you are very honest, and Thaka said food.”
Thaka: “as long as it’s good food, good food”
Young women, Soweto, 16-18 years FGD
Another facilitator discussed by young women and men was how
research participation facilitated access to knowledge around
1In order to ensure that participants were able to pay for transport and were
acknowledged for their time, AYAZAZI participants received small honorariums
for participation, and were provided something to eat at each study visit.
2All names are pseudonyms chosen by youth.
HIV and helped to provide information about new HIV
technologies such as HIV vaccines. For example, Busi in Durban
(16–18 years FGD) shared that, “I would get more knowledge
about the HIV vaccine and how it helps us and people, not only
young people actually.”
Participants also expressed how they would want to participate
for altruistic purposes in order to benefit their communities.
Paul: “I think it will be a benefit for my country and other people
related to me because if I take part of the study and the study works
out on me, positively so, and maybe the doctors will be able to,
through the study and the vaccine, to find a cure or something like
that. That. . . that’s what will motivate me.”
Young men, Soweto, 16-18 years FGD
Across all eight FGDs, participants discussed the potential
protective effects of participating in HIV prevention research.
Beyond the potential for preventing the acquisition of HIV,
women in Durban further discussed how participation in studies
taking vaginal or rectal swabs could potentially screen for other
diseases such as cancer.
Young men were particularly interested in the sexual
risk protection benefits to participating in HIV prevention
research. They admittedly discussed that at times when they get
intoxicated, they may not trust their own decision-making, thus
PrEP could protect them if they engaged in behaviors that may
expose them to HIV.
Sipho: “Yes, that PrEP keeps you on the safe side you see. It keeps
you on the safe side, when you are drunk, in things like that, you
sometimes go to the (night) clubs. In the (night) clubs you cannot
be sure that there is not even one person who has the virus in that
(night) club. Unfortunately, you will be the one who sleeps with the
person who has it. You co-incidentally find that you get someone
who has the virus and they won’t tell you that. What can make
me participate in PrEP (studies) is that it keeps you on the safe
side of things, even if something unexpected happens you will have
something protecting you. Ja.”
Young men, Durban, 16-18 years FGD
Both young women and men expressed concerns about side-
effects and were skeptical of the evidence behind some of the
technologies that were being tested within trials. In response to
a question asking why you would not take part in an HIV vaccine
trial, Thuli in Durban (young women 16–18 years FGD) replied,
“Because they’re still not sure of what would it do to your body.”
Young men in Soweto were also curious to know more about the
potential side-effects of PrEP.
Fader: “I want them to explain to me how it works in the body and
assure me that the side-effects won’t affect me in future, if I decide
to take this pill.”
Young men, Soweto, 16-18 years FGD
Young men were particularly skeptical about participating in
studies collecting rectal and sperm samples. Some young men
discussed how they would not participate because they had
too much ‘pride’, feared the procedure would be painful or
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TABLE 2 | Characteristics of AYAZAZI participants in focus group discussions (FGDs), overall and by gender (n = 65).
Socio-demographic Characteristics Overall n (column%) Young women (n = 31) (%) Young men (n = 34) (%)
Site
Durban 31 (47.7) 15 (48.4) 16 (47.1)
Soweto 34 (52.3) 16 (51.6) 18 (52.9)
Age median Q1, Q3 18 (17–21) 18 (17–22) 18 (17–20)
Sexual Orientation
Lesbian, Gay, or Bisexual 6 (9.2) <5 <5
Heterosexual 59 (90.8) – –
Have Children
No 50 (77.0) 19 (61.3) –
Yes 15 (23.1) 12 (38.7) <5
Live in Formal Housing
No (hostel, reconstruction development project, shack) 16 (24.6) 10 (32.3) 6 (17.7)
Yes 49 (75.4) 21 (67.7) 28 (82.4)
Willing to participate in HIV vaccine trial?
Unwilling 18 (27.7) 8 (25.8) 10 (29.4)
Neutral 19 (29.2) 12 (38.7) 7 (20.6)
Willing 28 (43.1) 11 (35.5) 17 (50.0)
Percentages by gender are calculated by column and in order to protect participant confidentiality are not displayed if cell count was less than 5.
uncomfortable, or would be worried that their sperm would be
donated, resulting in an unknown child.
Shaka: “Maybe you can say that its pride, one’s pride that is within
them, they were born with it, that no you do not want a person to
touch you and you too you do not want to put something in a place
that was made, not for inserting anything. Ja.”
Young men, Durban, 16-18 years FGD
Interpersonal
Interpersonal relationships with peers, intimate partners, and
family/caregivers were shown to be important facilitators in
shaping young people’s willingness to participate in HIV
prevention research. These were expressed both as barriers
and facilitators.
Peers
Stigma and judgment from peers were seen as strong barriers to
participation in HIV prevention research, particularly for young
men. Some young men were concerned about peers judging their
participation in studies involving having to take anal or semen
samples. As Sjojo from Soweto (age 19–21) shared,
Sjojo: “Eh yha they’ll [friends] be this ones I’m going to feel
confident about to tell people, like the anal one eh I won’t because ah
I don’t feel comfortable to tell someone else my brother I’ll have to
yeh you see . . . something and stuff, then even this one for seminal
fluids and stuff I won’t feel comfortable to tell someone else that I
was masturbating and stuff cause obviously we know how a black
person can be like, you know ((laughing)) ((takes it)) make it a joke
when they see you they say here is this one who was masturbating
((laughing)) so yha so I can say yes and no.”
Young men, Soweto, 19-21 years FGD
However, when it came to participating in MMC trials,
young men discussed how peers could potentially facilitate
participation through peer pressure due to societal norms around
circumcision. As Kagiso from Durban shared in disagreeing
to another participant claiming that young men only get
circumcised to protect themselves,
Kagiso: “What he is saying [that young men only get circumcised
to protect themselves] is right but partially it is wrong. It says there
is nothing that can cause someone to want to get circumcised. We
as guys growing up there is something that can cause this guy for
an example as he is not circumcised, we are all circumcised as guys,
peer pressure is there.”
Young men, Durban, 16-18 years FGD
Intimate partners
Although there was little discussion around intimate partners
being barriers to participation directly, young women discussed
whether or not they would want to be open with their
partners about participation. This could be seen as an indirect
barrier to participation if young women felt that they were
unable to disclose participation to their intimate partners.
Facilitators to participation were often motivated by distrust
of partners or the in ability to use condoms at times due to
intoxication, and the opportunity to access youth-controlled HIV
prevention modalities.
Female participants discussed how their willingness to
participate in research in which a vaginal swab was taken
would depend on the gender of the person collecting the swab,
especially if in a relationship. While some women expressed
that they felt that they should be discussing participating with
their partners, others felt that this would be problematic or
unnecessary. For example, in response to another young woman
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claiming she wouldn’t tell her partner about participating in an
HIV prevention trial, Ayanda exclaimed:
Ayanda: “I disagree a little bit with her but some of it is correct but
according to my opinion, like you have to sit down with him and tell
him that you are doing this for the sake of your relationship because
he is your partner. . . . Anything that is happening in your private
part like you are sexually active you are [having] sex with him.”
Young women, Durban 16-18 years FGD
However, others felt that they wouldn’t want their partners to
know that they were participating in research.
Hope: “I’ll go for it but my partner I won’t tell him because ((can’t
think of a reason)) ((laughing))”
Facilitator: “So, you would keep it a secret from your partner?”
Hope: “Yes, and if maybe neh, let’s say he checks himself [gets
tested] and he finds that he got it [HIV] ((laughing)) that means
he got it somewhere, I will know my status isn’t ? And he checked
without knowing.”
Young women, Soweto, 22-24 years FGD
Young women also discussed how they wouldn’t tell their
partners about participation in HIV trials because they would
likely be misinformed and have false beliefs around what will
happen to his partner while participating in the trial.
Fancy Face: “You said what if they check you neh at the clinic?
No, we won’t go to the clinic, I’ll tell him that isn’t you know I’m
attending a study here? No, my partner knows that I’m attending a
study here. But I won’t tell him about this vaccine, that I’m going
to get false HIV cause I know he’s crazy like, he’s stubborn like, like
he’s mentality it’s immature you see. So, I’ll say like. . . I’ll say they
going to put false HIV [get the HIV vaccine] and then he goes get it
elsewhere and then say I infected him, things like that”
Young women, Soweto 22-24 years FGD
While other young women discussed that participating in
research that allowed for more female-controlled methods could
help to protect them and give them power and could also
an opportunity for both partners to learn and be involved in
research together.
Mpho: “I would take part neh? Our partners’ neh? I can treat myself
nicely but immediately when he goes out, I don’t know he goes out
and with who, his sneaking where. So I would take it for my safety
like that, but anyway he knows, his also participating in the study
that we both stable.”
Young women, Soweto, 16-18 years FGD
Vaccine trials and PrEP were favored by women for access to
female controlled discrete options to protect themselves against
HIV when there is a lack of trust in the relationship (i.e., against
unfaithfulness; when condoms weren’t used). This is shown
through this statement from Hope:
Hope: “Most of the time my partner doesn’t use a condom. So
because I don’t know what he does, where he is, . . . I think if use
it maybe when he comes he will find me strong [protected from
HIV]. . . if he comes with the virus I won’t get it, maybe I am strong”
Young women, Soweto, 19-24 years FGD
Young men discussed how participating in biomedical HIV
prevention research could help to build a better future for them
and their future partners. Participating in this research may help
to find a cure and in turn reduce the fear of acquiring HIV with a
partner they might want to have children with.
Sipho: “Another thing that can make people participate is that, if
you now know that okay there is something available as a cure for
HIV most people will see life becoming easy because HIV is what
causes life to be difficult because as youth we sometimes when we get
old we become scared of having children cause the person you going
to have a child with you do not know whether they are positive or
negative unless if you do tests.”
Young men, Durban, 19-24 years FGD
Young men also acknowledged that taking PrEP in a trial would
be motivating as it could protect you from your partner who
might be “doing something on the side.”
Family/Caregivers
Family members, and specifically caregivers, were also mainly
considered as a barrier to participation. Some young women
discussed how they were worried about their parents finding out
about their participation, which resulted in some disagreement
about the role that caregivers should play in young women’s
health decision-making. Overwhelmingly, young women feared
that participating in HIV prevention research would ‘out’ them
as sexually active to their parents, with varying consequences. For
instance, Thanda explained:
Thanda: “So, now ja some can talk to you and stuff, but parents are
different some can even chase you away from your home, so you see
those things.”
Young women, Durban 16-18 years FGD
This quote also highlights how for young women under 18 years
of age, having to disclose to parents the criteria for participation
may cause significant barriers for adolescent women under the
age of consent. Even when participants may be old enough to
consent to participate, barriers such as asking caregivers for
transport moneymay also be a significant barrier to participation.
Busi: “Even though they would want to participate, because of
certain reasons at home. . . Transport - the procedure of asking for
money. Where do you say you are going? Parents will say we will
take you there because you are still a teenager, still young, we are
going to treat you like that and now you are doing things that are
being done by adults. You will be judged also, things like that.”
Young women, Durban 19-24 years FGD
Young women also feared that to parents, study participation
would suggest risky sexual behavior and expressed concerns
about a lack of privacy if asked to collect vaginal or seminal
samples at home.
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Faith: “Parents, naughty parents, who just dig in your bag and will
find everything and ask now what are you doing no [talking and
laughing] like there are no boundaries [participants laugh] no, but
then like if your parent finds it they will find what they were looking
for [laughs] what do you want.”
Young women, Durban 19-24 years FGD
Participants in the same FGD spoke about the strong societal
stigmatization around the sexuality of young women. This
included some young women discussing how they may not want
to participate in HIV prevention research that might disclose to
their parents that they are sexually active, while others felt that
young women need to take control of their own health.
Thanda: “I say no I’m thinking about my parent like what would
she think when she finds out that I’m sexually active and stuff so,
some wouldn’t do it and ja.”
Ayanda: “I think it’s not about . . .what your parents think. It is
your future, it’s your life, you are the one who knows that now you
are sexually active you need to, to do this and this to prevent myself
from being you see, a laughing matter in the community.”
Young women, Durban, 16-18 FGD
Due to societal norms around young women’s gender roles and
sexuality, young women expressed that communicating with
parents was challenging. This is highlighted by a quote from Busi
discussing the lack of open dialogue between young Black South
Africans and their caregivers:
Busi: “As black children we are being discriminated that no, you
can’t do this thing they don’t tell us why they[parents] just say don’t
do this.”
Young women, Durban 19-24 years FGD
Young women aged 16–18 years old also highlighted a lack in
parental communication skills regarding HIV prevention and
family planning, which create barriers for young people to learn
and have an open dialogue about risk prevention and in turn the
ability to participate in research centered on preventing HIV.
Londi: “Some parents though, they do not judge by looking they
wait maybe until they prove by themselves when that particular
time comes but sooner or later your parent will find out. But then
Ayanda is also right if your parent, because they are parents as
Thanda has said, that they unable to sit down with their children
that is why most children end up getting pregnant and stuff because
a parent is scared to confront her child and tell the child that, you see
my child if it is like this and this that means this is what is supposed
to be happening”
YoungWomen, Durban, 16-18 years FGD
Community
During discussions of participation in other HIV prevention
research, young men expressed that social norms around
circumcision and community-level views of altruistic actions,
such as research participation, motivate young men to
participate. For example, in the younger aged male FGD in
Soweto, participants discussed how research participation could
help young men “earn a name in the community for doing
volunteer work.”
Other young men expressed potential fear in research
participation, as it could cause conflict, and this could lead to
violence in the community.
Shakes: “I would say no to being part of that group some people
will discriminate against you, they’ll judge you you see and call you
names. . . So that now will make the heart sore. You see. And that
can lead to conflict, then we end up fighting, stab each other, you
know things between men never end.”
Young men, Soweto 16-18 years FGD
While young men expressed concerns for being made fun of
by their peers for procedural elements to participating in HIV
prevention trials, young women feared that individuals in the
community would perceive them to be living with HIV if they
found out that they were participating in research.
Gugu: [In response to what barriers would prevent you from taking
part in trials] “Being stereotyped by people. [. . . ] When they see you
outside and seeing that you are taking medication, they might think
that you are HIV positive maybe, ja that kind of stuff.”
Young women, Durban, 16-18 years FGD
In order to resist some of societal level norms around sexual
behavior and stigma attached to parents and other knowing about
their sexual experience, young women discussed ways in which to
mediate risks for participating in research (taking the power back
into their own hands). For example, Ayanda in Durban shared,
Ayanda: “Like maybe let’s say Zonke is my friend and I share lot of
things with her and she will come and tell me that okay friend if it is
like this you should do this and this like you don’t have to really tell
your parents if you don’t feel comfortable. You can do your things
like aside, in private.”
Young women, Durban 16-18 years FGD
This also demonstrates the trust, community and friendship
created among the participants in AYAZAZI.
Structural/Societal
Health care services and youth-friendly study environments
Participants discussed that interactions with health care
providers in their community could often be challenging as their
social networks are very interconnected, and they often know the
health care providers personally. Young women expressed how
this led to institutional distrust and anxiety around health care
providers disclosing personal information to their parents.
Thola: “And what is painful is that the clinics, usually you can go to
the ones that are around home ((local area)), so if a nurse sees you
there and knows your parent you will be scared and end up maybe
not doing all the tests that you went there for and say okay, ((what
if / imagine)) I will do the pregnant test and if it comes out positive
the first person that would know is this mother ((nurse)) and this
mother will tell my mother.”
Young women, Durban 19-24 years FGD
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However, young women and men both discussed how
participating in the AYAZAZI study allowed them to build
trust, have more confidentiality and gain access to youth-friendly
services. This was compared by participants to regular clinic
visits where the lack of confidentiality was presented as a barrier
to attending. As expressed by one young women 20–24 years
from Soweto “I came here because I didn’t like to go to the clinic
to check”.
Distrust of health care provided in young women’s
communities was a common theme among young women
in Durban as well, thus having the option of attending a
clinic outside of their community that provided youth-friendly
sexual health services facilitated young people to participate in
our study.
Noma: “What made me love AYAZAZI the most is the fact that you
always know your body like maybe if you have STIs as [mentioning
note taker’s name∗] has mentioned that they first test you ((blood
tests)), then they test you about yourself. So that thing makes me
love AYAZAZI and also as they’ve already ((other participants))
said not going to the clinic in your community. What irritates me
the most is that the nurses will pass the news, when they know each
other they will keep chatting you see.”
Young women, Durban 19-24 years FGD
Young men discussed how accessing care and services through
research participation allowed for easier (less time consuming)
access to sexual health services.
Bheka: “[another] thing if it is said that they should come like to
the clinic, as my sister ((presenter)) was saying, like the process of
the study. If they get to the clinic and find that they will maybe wait
for like more than 3 hours, and that is what people don’t like. So
they want something that is quicker all the time. That is why I am
saying that maybe it’s 40% that would participate.”
Young men, Durban, 19-24 years FGD
The strong sense of community and belonging through
participation in AYAZAZI was emphasized by both young
women and young men. And that this sense of community that
AYAZAZI provided for youth was discussed as a strongmotivator
for participation in other youth-centered studies.
In Durban, young women discussed how they felt
participating in AYAZAZI allowed for them to build friendship
with other participants and felt supported by the study staff at
AYAZAZI. Precious (age 16–18) exclaimed “The AYAZAZI team
is so supportive I just love them all.” In Soweto the younger
aged women also discussed how participating in AYAZAZI
provided opportunity to build friendships and learn from other
young people.
Aphiwe: “ey it’s funny here hey man we get to know each other
meeting different people yah”
Lena: “okay, that’s fine”
Kagiso: “you get to learn about lot of things uhm get to know each
other the the the groups opinions. . . yah”
Young women, Soweto 16-18years FGD
Cross-Cutting Barriers and Facilitators
Social norms and gender inequities shaped willingness to
participate in hypothetical biomedical HIV prevention research
across all levels of the ecological model. For young men, societal
level norms around the acceptance of male sexuality allowed for
young men to be seen as altruistic and heroic for participating
in research. While, at the same time young men feared being
judged by peers for participating in research practices that were
seen as unmasculine or shameful. For young women, societal
level taboos around young women’s sexuality created barriers
for young women’s participation in HIV prevention research
which often requires young women to have had a history of
sexual activity in order to be eligible or need parental consent
if the participant is under the age of 18. Trust and distrust
also operated on all levels to influence young women and men’s
willingness to participate in research. For example, mistrust of
partners, parents, study procedures, skepticism around research
evidence, and historical mistrust of health services due to
negative encounters with health care providers were commonly
discussed. Research participation willingness was facilitated by
approaches that were youth-centered, and allowed for ease of
access to information, services, support, care, trust, and a sense
of belonging.
DISCUSSION
Our results of multi-leveled barriers and facilitators demonstrate
that young men and women are interested in participating in
biomedical HIV prevention research, but research programs
need to be designed with their daily social realities in mind.
Gender and power inequities affected youth’s willingness to
participate in biomedical HIV prevention trials, on individual,
interpersonal, community, and structural levels. While distinct
and gendered barriers and facilitators were noted within each
level of the ecological model, societal gender norms and trust
and mistrust cut across all levels to influence young women
and men’s willingness to participate in hypothetical biomedical
HIV prevention research. Moreover, at each level young people’s
desire for youth-friendly sexual health services and information
were noted by young women and men as key facilitators
to participation.
Societal Level Gender Norms
Adolescence is a transformative time period in which behavioral
motivation is highly influenced by societal norms (19). Our
results highlight how differences about whether to participate
in hypothetical biomedical HIV prevention research are highly
gendered and occur along societal expectations of what it means
to be a young man or a young woman in South Africa. For
young women, decisions were based largely on external factors
including intimate partners, parents and societal perceptions of
what participating in HIV prevention research would say about
young women’s sexuality and sexual behaviors. Whereas, for
young men, decisions were more based on individual factors or
peer-to-peer perceptions—specifically what other young men in
their communities would think about them.
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Healthy adolescent development includes increased decision-
making capacity (19). In many global contexts, however, societal
gender norms resist young women’s individualism and decision-
making power (33). One element of Connell’s theory of gender
and power is the gendered division of power, which is most often
described on an interpersonal level between men and women
in relationships. This conceptualization of power inequities
within Connell’s theory may be too narrowly focused on
intimate relationship dynamics. Expanding this theory to other
relationships including parents, peers and healthcare workers can
help to conceptualize the complexity of power dynamics that
young women must navigate in order to build their decision-
making capacity across the life course (33, 34). Conversations
that occurred among women in this study highlighted that
navigating behavioral control and monitoring by parents and
caregivers was one important barrier to research participation as
well as accessing health care generally. The gender differences in
parental perceptions and barriers to participation were contrary
to a previous study conducted in Tanzania indicating that men
were much more likely to decline participation in HIV vaccine
trials due to parental concern for young men’s health (33, 35–37).
Parental control and monitoring has been previously discussed
as a common occurrence for young women growing up in sub-
Saharan Africa, and an important determinant of sexual behavior
among adolescents and young adults in sub-Saharan Africa
(33, 38, 39). Thus, while young men may face some parental
discouragement once they’ve enrolled in the study, due to fear
of their child’s safety, parental control and monitoring may be
more of a barrier for young women to enroll into a study in the
first place. While some young women discussed the challenges of
communicating choices to controlling parents, others navigated
and resisted these controls by choosing not to communicate
decisions around research participation. This may be a choice
for young women wishing to participate in research who are able
to consent for themselves, however remains a major hurdle for
young women wishing to participate in research needing parental
consent (40).
These findings highlight the gendered dynamic in sexual
health studies among adolescents and young adults, whereby
young women tend to receive ‘blame’ for adolescent pregnancy,
HIV, etc., while young men rarely face this. Conversations
within the FGDs reflect how young women experience shame
and stigma regarding their sexuality, when sexual experience
is required for research eligibility, whereas young men in the
study were more likely to highlight that research participation
would be viewed positively in their communities, potentially
giving themmore recognition, even allowing for them to increase
their social stature. As young women move from childhood,
through adolescence and into adulthood, they must navigate
the different relationships they have been embedded within
while they begin to form new relationships and make important
decisions for themselves (41, 42). Although some discussions
highlighted how young women navigated decisions regarding
communicating research participation, societal pressures to
conform to standards of femininity within young women’s
communities needs to be further acknowledged and understood
(23, 43). The results from this study showcase how interacting
relationships and societal pressures influence young women’s
willingness to participate in biomedical HIV prevention research,
as well as their ability to communicate with partners, peers, and
family about research participation.
Distrust in Partners, Procedures, and
Healthcare Professionals
Distrust was addressed by both young men and women,
exploring personal relationships as well as perceptions of health
care professionals, procedures and systems. These perceptions,
however, were gendered. Young women discussed mistrust of
their own intimate partners in two main ways. Some young
women did not trust their partners enough to share with them
about research engagement. Distrust of their partners was also
presented as a motivator to participation, particularly if they
perceived or suspected their partners to have other sexual
partners. They recognized that their involvement in the study
procedures could protect them from HIV and other STIs. These
discussions are in line with much of the PrEP literature which
centers on the ability for this HIV preventionmodality to bemore
women-centered and controlled (44).
Our findings also highlighted young men’s distrust in their
own behaviors and their perceptions that PrEP could be useful
in the short-term when engaging in activities (such as binge
drinking) that may result in condomless sex and in turn increase
the likelihood of acquiring HIV. While some research has
examined the role of alcohol use on PrEP decision-making for
young men who have sex with men (45, 46), there is limited
research on motivations for PrEP use and PrEP implementation
research participation among young men in heterosexual sexual
relationships. Results further highlight the positive outlook on
the future held by young men who were excited about the
future implications that PrEP could have for starting a family in
potentially sero-discordant partnerships.
In relation to institutional mistrust, young men were
more likely to discuss their distrust for research procedures,
particularly surrounding the collection of samples. These
findings are in line with previous research conducted in the
United States, highlighting high levels of medical distrust
among young men living with HIV (47). Young women also
discussed distrust of health care professionals due to issues
of confidentiality and perceived judgements regarding young
women’s sexuality. This is further influenced by the discretionary
power of health care workers, in which some women spoke about
fearing health care workers will disclose information about STIs
and sexual behaviors to their parents. Neglect for confidentiality
is a common narrative among South African’s interaction
with the health care system (48). Across genders, young men
and women discussed both real and potentially misinformed
worries and skepticism regarding participation in biomedical
HIV prevention trials. Misconceptions about trials procedures
or effects influenced both young men and women’s decision to
participate as well as their decisions to discuss their participation
with others. Similar to previous research highlighting the reasons
for declining to participate in an HIV vaccine trial (33, 35–
37), participants discussed how perceptions of the trials in the
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community, including the belief that an HIV vaccine could give a
participant HIV or false-positive HIV status, would be influential
in their decision to participate (49, 50). Thus, it is critical for
young people to trust confidentiality processes and are provided
with trusted, reliable, adequate and clear information about HIV
vaccines and other biomedical modalities as well as both the
benefits and potential side-effects from trial treatments.
Young People’s Desire for Youth-Friendly
Services and Information
Overwhelmingly, young women and men in our study were
willing to participate in HIV prevention trials, a finding similar
to other studies conducted with youth in sub-Saharan African
settings (49, 51). Youth had to weigh the benefits, access to youth-
friendly services and information against fears of potential side-
effects. Even after enrollment, previous studies have found that
participants may drop-out due to fears about side effects (33, 35–
37). Over the 12 months of follow-up in our cohort study, 95% of
participants were retained in AYAZAZI. Although our study was
not a biomedical trial, these results highlight how the desire for
continuous access to appropriate, responsive, and youth-friendly
sexual health services was strongly conveyed by young women
and men in this study. Though it was a research study, AYAZAZI
and the youth-engaged approach, provided a welcomed window
into youth-friendly and youth-centered sexual health services,
where they experienced positive, supportive relationships with
staff and their peers. Young people may not feel comfortable
discussing their sexual health with their family members, and
often instead turn to their friends for advice and support (52).
Research participation has provided opportunities for youth to
learn more about HIV and ways in which they can protect
themselves. Such opportunities, they noted were rarely provided
at home, in the community, or within educational and health
care institutions. Motivations for participation in hypothetical
biomedical HIV prevention research were commonly centered
on the desire to access youth friendly sexual health services
and information, similar to the experiences they had while
participating in AYAZAZI, highlighting that young people feel
that participating in sexual health related research may be one
of the few opportunities to gain access to these services (53–55).
Recommendations
Many young women discussed how they find it challenging
to discuss their sexual health with their parents and that
participating in HIV prevention trials may disclose to their
parents that they are sexually active, which would prevent them
from participating. Results highlight the lack of parent-child
communication among many adolescents and young adults in
South Africa and their families (56, 57). Efforts are needed to
engage with parents, guardians and caregivers to support them
in learning how to effectively communicate with their children
about sex and HIV, particularly in a setting with high STI and
HIV prevalence. These efforts may include virtual tools that can
support challenging child-parent conversations (58). However,
in order for parents to be able to talk to their children about
taboo topics like sexuality, they need opportunities to discuss
their own experiences as young people and sexuality in general.
Thus, efforts to engage parents and caregivers in dispelling
myths, communicating accurate information and building a
repertoire of vocabulary for which to use with their children are
needed. Previous research with youth and caregivers in Soweto
highlighted that within households without male caregivers,
young women and men often take responsibility for their own
health care, while also feel the need to educate caregivers on
the importance of health promoting decisions (e.g., getting
vaccinated for HPV) (17). Thus, parental supports may also
include efforts aimed at bringing parents and caregivers of youth
together to support one another and learn about emerging HIV
prevention and other sexual health promotion technologies and
programming. Finally, given the importance of peer relationships
for youth, HIV research wishing to recruit young people should
seek to enhance and build on peer-to-peer messaging.
While societal-level norms may make it easier for young
men to participate in research, gender specific barriers, such
as medical mistrust may prevent young men from engaging in
research. Thus, efforts are needed to build trust with young
men who have been historically disadvantaged by the health
care system in South Africa (48, 59). Also, community-based
programming aimed at shifting and transforming harmful
gender norms and attitudes are critical for young women’s
agency in decision-making such as participation in research
that is highly stigmatized in communities with engrained
patriarchal hierarchies (60). Results from this study highlight
the critical need to take into account gender and power
relationships in designing HIV trials, and more broadly in
responding to HIV prevention needs and youth friendly sexual
and reproductive health services more generally. Given the
successes in retaining and supporting participants through the
youth-engaged approach undertaken by AYAZAZI, there is a
critical need to improve and build upon existing youth-engaged
approaches in order to successfully involve and retain young
people in HIV research.
Limitations
Focus groups were conducted among youth who were already
participating in an HIV-related study that required biological
sample collection, as such the views of these young people were
likely more positive toward research participation than all South
African youth. Thus, it is likely that the findings discussed
herein cannot be generalized to all young trial naïve people in
South Africa. Finally, in using FGDs while efforts were made
to encourage and facilitate each individual to provide their
opinions, given the group dynamic some participants may not
have felt comfortable expressing their opinions.
CONCLUSION
In order to enhance the efficacy, acceptability, and uptake of
biomedical HIV prevention technologies there is a critical need
to involve adolescents and young adults living at the epicenter
of the HIV epidemic into research. Our study highlights that
there are a plethora of barriers and facilitators that may impact
youth’s participation in biomedical HIV prevention research that
run along gendered lines. This needs to be taken into account
in designing future research and sexual and reproductive health
programs. Societal gender norms, power dynamics and mistrust
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within intimate relationships, family households and society
as a whole disproportionately affect young women’s decision-
making practices surrounding participation in research. Future
research needs to take into consideration these lived realities
and work toward involving families and creating youth-engaged
research environments and opportunities which seek to redress
inequitable gender relations.
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